Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Fertil Steril ; 92(6): 1820-4, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18930214

RESUMO

OBJECTIVE: To characterize human endometrial HOXA10 expression in patients using a copper intrauterine device (IUD). DESIGN: Case-control study. SETTING: Academic medical center. PATIENT(S): Women using copper IUDs. INTERVENTION(S): Immunohistochemical analysis of endometrial HOXA10 expression in biopsy samples obtained from 24 women using a copper Paraguard T380A as well as in samples obtained from 10 normal cycling women who were not using an IUD or hormonal contraceptives. MAIN OUTCOME MEASURE(S): Endometrial HOXA10 expression. RESULT(S): Endometrial HOXA10 expression was markedly decreased in the biopsy samples obtained from women using the IUD contraceptive when compared with controls. The mean H score for endometrial stromal cell HOXA10 expression in samples obtained from women using the Paraguard IUD was 0.21 compared with 2.2 in the control endometrial biopsy samples. Endometrial glandular expression of HOXA10 was absent in all IUD users. CONCLUSION(S): Decreased endometrial HOXA10 expression was apparent in women who use a copper IUD. Expression of HOXA10 is essential for endometrial receptivity. A novel mechanism of copper IUD action involves suppression of genes required for endometrial receptivity. The dramatic decrease of endometrial HOXA10 in response to IUD use may contribute to contraceptive efficacy.


Assuntos
Cobre , Endométrio/metabolismo , Fertilidade/fisiologia , Proteínas de Homeodomínio/metabolismo , Dispositivos Intrauterinos , Adulto , Fatores Etários , Biópsia , Endométrio/citologia , Feminino , Proteínas Homeobox A10 , Humanos , Imuno-Histoquímica , Ciclo Menstrual/metabolismo , Células Estromais/metabolismo , Adulto Jovem
2.
Am J Physiol Endocrinol Metab ; 292(2): E435-42, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16985261

RESUMO

HOXA10 is necessary for normal development of the Müllerian duct, and continued adult expression in the uterus is necessary for female fertility. HOXA10 expression is altered by diethylstilbestrol, leading to uterine anomalies. Other endocrine disruptors may potentially lead to reproductive anomalies or dysfunction by altering HOXA10 expression. Here we investigated the effect of isoflavones on HOXA10 expression after in utero or adult exposure in the mouse. Genistein, but not diadzein, regulated HOXA10 mRNA and protein expression in the adult mouse uterus. In contrast, in utero genistein or diadzein exposure had no lasting effect on HOXA10 expression in the exposed offspring. Reporter gene expression driven by the HOXA10 estrogen response element was increased in a dose-responsive manner by genistein, but not daidzein. Neither estrogen receptor-alpha nor estrogen receptor-beta binding to the HOXA10 estrogen response element was affected by genistein or daidzein. In utero exposure to isoflavones is unlikely to result in HOXA10-mediated developmental anomalies. Adult genistein exposure alters uterine HOXA10 expression, a potential mechanism by which this agent affects fertility.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Proteínas de Homeodomínio/metabolismo , Fitoestrógenos/farmacologia , Prenhez , Efeitos Tardios da Exposição Pré-Natal , Útero/embriologia , Animais , Células Cultivadas , Proteínas de Ligação a DNA/metabolismo , Feminino , Genes Reporter/efeitos dos fármacos , Genisteína/efeitos adversos , Genisteína/farmacologia , Proteínas Homeobox A10 , Proteínas de Homeodomínio/genética , Humanos , Isoflavonas/efeitos adversos , Isoflavonas/farmacologia , Troca Materno-Fetal , Camundongos , Camundongos Endogâmicos , Fitoestrógenos/efeitos adversos , Gravidez , Prenhez/efeitos dos fármacos , Efeitos Tardios da Exposição Pré-Natal/metabolismo , Receptores de Estrogênio/metabolismo , Elementos de Resposta/efeitos dos fármacos , Útero/efeitos dos fármacos , Útero/metabolismo
3.
Mol Endocrinol ; 19(11): 2839-46, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15994197

RESUMO

The molecular mechanisms that underlie embryo implantation are poorly understood. Under the control of sex steroids, uterine endometrium undergoes tremendous, yet tightly controlled, proliferation in each estrous cycle to facilitate implantation; disorders of endometrial proliferation underlie several uterine diseases. We have previously identified the Emx2 gene as a transcriptional target of HOXA10 regulation in the reproductive tract. Here we report the function of Emx2 in murine implantation and regulation of endometrial proliferation. We transfected mice on d 2 post coitus with pcDNA3.1/Emx2, Emx2 antisense, or respective controls consisting of empty pcDNA3.1 or a random order oligonucleotide by intrauterine lipofection. Increased expression of Emx2 reduced average implantation rate by approximately 40% (P = 0.00006) resulting in an average number of implanted embryos per litter of 13.7 in the control group to 8.2 in the pcDNA3.1/Emx2-treated group. Neither treatment altered the number of mice attaining pregnancy with at least one embryo. Decreased Emx2 expression did not alter litter size. Neither treatment affected the birth weight of the pups. To elucidate potential mechanisms through which Emx2-regulated reproduction, markers of endometrial differentiation, proliferation, and apoptosis were assessed. Increased Emx2 expression significantly decreased endometrial cell proliferating cell nuclear antigen expression and 5'-bromo-2' deoxyuridine incorporation. Markers of stromal cell differentiation (IGF binding protein-1, prolactin), epithelial differentiation (calcitonin), and apoptosis (activated caspase3) were unchanged. In human endometrial epithelial cells in vitro, Emx2 reduced cell number indicating diminished proliferation. Emx2 controls mammalian reproduction by adjusting endometrial cell proliferation without effecting differentiation. Regulated uterine Emx2 expression is necessary during reproduction for maximal implantation and litter size.


Assuntos
Implantação do Embrião , Endométrio/fisiologia , Proteínas de Homeodomínio/metabolismo , Tamanho da Ninhada de Vivíparos , Animais , Apoptose , Biomarcadores/metabolismo , Diferenciação Celular , Proliferação de Células , DNA Antissenso/genética , Regulação para Baixo , Implantação do Embrião/genética , Endométrio/citologia , Feminino , Proteínas de Homeodomínio/antagonistas & inibidores , Proteínas de Homeodomínio/genética , Humanos , Tamanho da Ninhada de Vivíparos/genética , Camundongos , Gravidez , Reprodução/genética , Células Estromais/fisiologia , Fatores de Transcrição , Regulação para Cima
4.
Endocrinology ; 146(8): 3445-51, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15890768

RESUMO

Methoxychlor (MXC) is a pesticide that has adverse effects on reproductive capability in mice. MXC and its metabolites bind the estrogen receptor and function as endocrine disruptors. MXC diminishes the uterine decidual cell response, necessary for the support of pregnancy. Hoxa10 is an estrogen-regulated gene that is an essential mediator of the decidual response and necessary for pregnancy. Here we demonstrate that a mechanism by which MXC disrupts uterine function is by suppressing Hoxa10 expression. MXC treatment of mice produced a mild uterotropic response as measured by increased uterine weight and epithelial height. MXC treatment of uterine Ishikawa cells in vitro induced Hoxa10 expression. Estrogen receptor (ER) binding to the HOXA10 estrogen response element (ERE) was promoted by treatment with estradiol (E2); however, MXC disrupted E2/ER/ERE complex formation and gel shift. MXC alone allowed weak ER/ERE binding. In vivo MXC blocked the effect of E2 on Hoxa10 expression. Neonatal MXC treatment resulted in an immediate suppression and cellular restriction of Hoxa10 expression as well as a permanent generalized decrease in expression that persisted in the adult. MXC inhibited the expression of Hoxa10, a gene necessary for uterine development and function. One common mechanism by which endocrine disrupting chemicals produce lasting reproductive tract defects is through permanent alteration of developmental gene expression.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Inseticidas/toxicidade , Metoxicloro/toxicidade , Útero/fisiologia , Animais , Animais Recém-Nascidos , Células Cultivadas , Células Epiteliais/efeitos dos fármacos , Feminino , Genes Homeobox , Proteínas Homeobox A10 , Proteínas de Homeodomínio/genética , Camundongos , Tamanho do Órgão/efeitos dos fármacos , Útero/anatomia & histologia , Útero/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...